| Trademark Snap Shot Publication & Issue Review Stylesheet (Table presents the data on Publication & Issue Review Complete) |
|||
OVERVIEW |
|||
| SERIAL NUMBER | 85686242 | FILING DATE | 07/25/2012 |
| REG NUMBER | 0000000 | REG DATE | N/A |
| REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
| INTL REG # | N/A | INTL REG DATE | N/A |
| TM ATTORNEY | EULIN, INGRID C |
L.O. ASSIGNED | 111 |
PUB INFORMATION |
|||
| RUN DATE | 10/05/2013 | ||
| PUB DATE | 12/25/2012 | ||
| STATUS | 819-SU - REGISTRATION REVIEW COMPLETE | ||
| STATUS DATE | 10/04/2013 | ||
| LITERAL MARK ELEMENT | BLOXIVERZ | ||
| DATE ABANDONED | N/A | DATE CANCELLED | N/A |
| SECTION 2F | NO | SECTION 2F IN PART | NO |
| SECTION 8 | NO | SECTION 8 IN PART | NO |
| SECTION 15 | NO | REPUB 12C | N/A |
| RENEWAL FILED | NO | RENEWAL DATE | N/A |
| DATE AMEND REG | N/A | ||
FILING BASIS |
|||||
| FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
| 1 (a) | NO | 1 (a) | YES | 1 (a) | NO |
| 1 (b) | YES | 1 (b) | NO | 1 (b) | NO |
| 44D | NO | 44D | NO | 44D | NO |
| 44E | NO | 44E | NO | 44E | NO |
| 66A | NO | 66A | NO | ||
| NO BASIS | NO | NO BASIS | NO | ||
MARK DATA |
|
| STANDARD CHARACTER MARK | YES |
| LITERAL MARK ELEMENT | BLOXIVERZ |
| MARK DRAWING CODE | 4-STANDARD CHARACTER MARK |
| COLOR DRAWING FLAG | NO |
CURRENT OWNER INFORMATION |
|
| PARTY TYPE | 20-OWNER AT PUBLICATION |
| NAME | Éclat Pharmaceuticals, LLC |
| ADDRESS | 699 Trade Center Boulevard, Suite A Chesterfield, MO 63005 |
| ENTITY | 16-LTD LIAB CO |
| CITIZENSHIP | Delaware |
GOODS AND SERVICES |
|
| INTERNATIONAL CLASS | 005 |
| DESCRIPTION TEXT | Injectable medication used to reverse anesthesia |
GOODS AND SERVICES CLASSIFICATION |
|||||||
| INTERNATIONAL CLASS | 005 | FIRST USE DATE | 07/26/2013 | FIRST USE IN COMMERCE DATE | 07/26/2013 | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
| CHANGE IN REGISTRATION | NO |
PROSECUTION HISTORY |
||||
| DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
| 10/05/2013 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 019 |
| 10/04/2013 | REGV | O | LAW OFFICE REGISTRATION REVIEW COMPLETED | 018 |
| 09/30/2013 | ALIE | A | ASSIGNED TO LIE | 017 |
| 09/21/2013 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 016 |
| 09/09/2013 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | 015 |
| 08/07/2013 | IUAF | S | USE AMENDMENT FILED | 014 |
| 08/30/2013 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | 013 |
| 08/07/2013 | EISU | I | TEAS STATEMENT OF USE RECEIVED | 012 |
| 08/07/2013 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | 011 |
| 08/05/2013 | ARAA | I | ATTORNEY REVOKED AND/OR APPOINTED | 010 |
| 08/05/2013 | REAP | I | TEAS REVOKE/APPOINT ATTORNEY RECEIVED | 009 |
| 02/19/2013 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 008 |
| 12/25/2012 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 007 |
| 12/25/2012 | PUBO | A | PUBLISHED FOR OPPOSITION | 006 |
| 12/05/2012 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 005 |
| 11/13/2012 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | 004 |
| 11/09/2012 | DOCK | D | ASSIGNED TO EXAMINER | 003 |
| 08/01/2012 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 002 |
| 07/28/2012 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
| ATTORNEY | Sofia Jeong |
| CORRESPONDENCE ADDRESS | Sofia Jeong Troutman Sanders LLP 600 Peachtree Street NE, Suite 5200 Atlanta, GA 30308 |
| DOMESTIC REPRESENTATIVE | NONE |
PRIOR OWNER INFORMATION |
|
| PARTY TYPE | 10-ORIGINAL APPLICANT |
| NAME | Éclat Pharmaceuticals, LLC |
| ADDRESS | Suite A 699 Trade Center Boulevard Chesterfield, MO 63005 |
| ENTITY | 16-LTD LIAB CO |
| CITIZENSHIP | Delaware |